Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Wakamoto Pharmaceutical

わかもと製薬

4512 · TSE · Pharmaceutical · 1 article

Financials Company only

Revenue¥9.91bn+27.2% year on yearCompany only · FY3/26

Ordinary profit¥256mCompany only · FY3/26

Dividend per share¥3.50FY3/26

Performance over time

Revenue
¥8.38bnFY3/22
¥8.66bnFY3/23
¥7.74bnFY3/24
¥7.79bnFY3/25
¥9.91bnFY3/26
Ordinary profit
¥72.3mFY3/22
¥243mFY3/23
−¥162mFY3/24
−¥409mFY3/25
¥256mFY3/26
Op. cash flow
¥339mFY3/22
¥632mFY3/23
−¥107mFY3/24
−¥592mFY3/25
−¥487mFY3/26

People & pay

Employees303 peopleFY3/26

Average salary¥5.65mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitEPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥9.91bn+27.2% year on year¥256.4m¥6.54¥3.50¥16.5bn¥12.0bn−¥487m
FY3/25¥7.79bn+0.7% year on year−¥409.2m¥1.85¥3.00¥15.0bn¥11.6bn−¥592m
FY3/24¥7.74bn−10.6% year on year−¥161.9m¥3.13¥3.00¥15.4bn¥12.0bn−¥107m
FY3/23¥8.66bn+3.3% year on year¥242.6m¥3.98¥3.00¥15.7bn¥11.9bn¥632m
FY3/22¥8.38bn¥72.3m¥6.87¥0.00¥15.0bn¥11.5bn¥339m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YDBU · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4512

Tokyo Brief coverage

All articles loaded · 1 shown

5% holders

Latest disclosed holders and exits below 5%.

1 holder · data through

5% holders
HolderStakeChangePurposeFiling
Asset Value Investors Limited
Original (Japanese)アセット・バリュー・インベスターズ・リミテッド
12.46%+0.82 ppMay make important proposals
Read full ownership purposeThe filer's holding purpose is pure investment, and the filer may undertake the following important proposals, etc. if it determines them necessary for the sustainable enhancement of the issuer's corporate value.・Disposal or acquisition of important property・Election or removal of representative directors・Appointment of a specific person as an officer・Important changes in the composition of officers・Transfer, acquisition, suspension or discontinuation of all or part of the business・Important changes in dividend policy・Important changes in capital policyThe filer has proposed to the issuer that, as a shareholder return, the issuer change to a policy of continuing dividends based on the Dividend on Equity Ratio from the current dividend payout ratio of 50% or more. The filer has proposed to the issuer that the issuer sell the rental and other real estate held by the issuer. The specific details, timing and conditions of important proposals, etc. other than the above are undetermined.
Machine translated
Original (Japanese)提出者の保有目的は純投資であり、発行者の持続的な企業価値の向上に必要であると判断した場合には以下の重要提案行為等を行う可能性がある。・重要な財産の処分又は譲受け・代表取締役の選定若しくは解職・特定の者の役員への選任・役員の構成の重要な変更・事業の全部又は一部の譲渡、譲受け、休止又は廃止・配当に関する方針の重要な変更・資本政策に関する重要な変更提出者は、発行者に対し、株主還元として、現在の配当性向50%以上から株主資本配当率(Dividend on Equity Ratio)により配当を継続する方針に変更するように提案している。提出者は、発行者に対し、発行者が保有する賃貸等不動産を売却するように提案している。上記以外の重要提案行為等の具体的な内容、時期及び条件については未定である。
Filed  — filing S100ZE0V

AGM votes

This season’s shareholder voting results.

1 meeting · data through

AGM votes
ProposalApprovalResultFiling
Appropriation of surplus
Original (Japanese)剰余金処分の件
99.23%Votes cast: 99.61%ApprovedFiled  — filing S100YKND
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 平井 友行
85.75%Votes cast: 86.07%ApprovedFiled  — filing S100YKND
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 五十嵐 新
85.71%Votes cast: 86.04%ApprovedFiled  — filing S100YKND
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 葛西 洋芳
86.00%Votes cast: 86.33%ApprovedFiled  — filing S100YKND
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 谷口 誠
85.99%Votes cast: 86.31%ApprovedFiled  — filing S100YKND
Election of 1 audit committee director
Original (Japanese)監査等委員である取締役1名選任の件
· 樋川 加奈
98.93%Votes cast: 99.30%ApprovedFiled  — filing S100YKND
Partial amendment of the articles of incorporation regarding formulation of a medium-term management plan for enhancing shareholder valueMachine translated
Original (Japanese)株主価値向上に向けた中期経営計画策定に関する定款一部変更の件
17.08%Votes cast: —RejectedFiled  — filing S100YKND

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

6 fiscal years · data through

Balance-sheet value
¥2.06bnFY3/22
¥2.47bnFY3/23
¥2.43bnFY3/24
¥1.84bnFY3/25
¥2.24bnFY3/26
Sale proceeds
¥421mFY3/22
—FY3/23
¥576mFY3/24
¥490mFY3/25
—FY3/26

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 202614¥2.24bn———Filed  — filing S100YDBU
Show 5 more fiscal years (6 total)
Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 202514¥1.84bn—3¥490mFiled  — filing S100W0QM
31 Mar 202416¥2.43bn—5¥576mFiled  — filing S100TTRJ
31 Mar 202320¥2.47bn———Filed  — filing S100R6G7
31 Mar 202220¥2.06bn—1¥421mFiled  — filing S100OCE2
31 Mar 202121¥2.46bn———Filed  — filing S100LMJG